Through our unique approach, the Target ALS Innovation Ecosystem, we are transforming the field of ALS research. Industry and academia are working more closely than ever, and an array of promising therapeutic options are poised for translation into clinical trials. Make a gift to today to accelerate the development of breakthrough therapies for patients.

“We hope you will join us. Together we can and we will win this fight.” –Daniel L. Doctoroff, Founder